# Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients

> **NCT01167153** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 564 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Valsartan/Amlodipine
- **DRUG:** Nifedipine

## Key facts

- **NCT ID:** NCT01167153
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 564 (ACTUAL)
- **Last updated:** 2012-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01167153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01167153, "Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01167153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*